BeOne Medicines (NASDAQ:ONC) has outperformed the market over the past 10 years by 13.23% on an annualized basis producing an average annual return of 26.69%. Currently, BeOne Medicines has a market capitalization of $29.88 billion.
Buying $100 In ONC: If an investor had bought $100 of ONC stock 10 years ago, it would be worth $1,057.17 today based on a price of $288.00 for ONC at the time of writing.
<h3>BeOne Medicines's Performance Over Last 10 Years</h3>
<img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1779209136_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="comp_fig" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1779209136_0.png"/>

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IBBQ

BeOne Medicines (NASDAQ:ONC) has achieved an annualized return of 26.69% over the past decade, outperforming the market by 13.23%. A $100 investment in ONC 10 years ago would now be worth $1,057.17, reflecting the significant impact of compounded returns. The company's current market capitalization stands at $29.88 billion.

benzinga_article

Beigene

VG Health

Invesco Nasdaq Biotechnology ETF

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

iShares US Pharma

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

Here's How Much $100 Invested In BeOne Medicines 10 Years Ago Would Be Worth Today